规模5亿元！巴南设立重庆第一支智慧医疗装备基金

Group 1 - The establishment of the Honghui Yuyi Fund marks the first smart medical equipment fund in Chongqing, with a scale of 500 million yuan, where 80% of the raised funds will be invested in the healthcare sector, contributing to the high-quality development of the biopharmaceutical industry in the region [1] - The biopharmaceutical industry is a key focus within Chongqing's "33618" modern manufacturing cluster system, identified as a trillion-level key industry, essential for upgrading the manufacturing sector towards high-end and intelligent development [1][2] - The fund aims to invest in core areas such as innovative drugs, medical devices, and medical consumables, targeting high-growth and innovative potential enterprises, while also pursuing long-term stable asset appreciation [2] Group 2 - Nantou Group has established 10 strategic industry guidance funds with a total scale of 4.53 billion yuan, primarily targeting the biopharmaceutical and optoelectronic sectors, and has invested in 36 projects [2] - The healthcare sector is experiencing a dual windfall from policy support and increasing demand, driven by factors such as global population aging and rising chronic disease rates, leading to a surge in demand for innovative drugs and medical equipment [2] - Honghui Fund (HLC), the fund manager, manages nearly 30 billion yuan in dual-currency funds and has invested in over 180 companies, with a successful exit from 82 companies, including 32 through IPOs, indicating strong potential for the new fund [3]